Vergara EJ - Search Results

1

Immunogenicity of PE18, PE31, and PPE26 proteins from Mycobacterium tuberculosis in humans and mice.

García-Bengoa M, Vergara EJ, Tran AC, Bossi L, Cooper AM, Pearl JE, Mussá T, von Köckritz-Blickwede M, Singh M, Reljic R. García-Bengoa M, et al. Among authors: vergara ej. Front Immunol. 2023 Dec 6;14:1307429. doi: 10.3389/fimmu.2023.1307429. eCollection 2023. Front Immunol. 2023. PMID: 38124744 Free PMC article.

2

Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target Mycobacterium tuberculosis Infection.

Bellini C, Vergara E, Bencs F, Fodor K, Bősze S, Krivić D, Bacsa B, Surguta SE, Tóvári J, Reljic R, Horváti K. Bellini C, et al. Bioconjug Chem. 2023 Oct 18;34(10):1738-1753. doi: 10.1021/acs.bioconjchem.3c00273. Epub 2023 Aug 22. Bioconjug Chem. 2023. PMID: 37606258 Free PMC article.

3

Serological analysis reveals differential antibody responses between TB patients and latently infected individuals from the TB endemic country of Mozambique.

Tran AC, Boariu E, García-Bengoa M, Kim MY, Vergara EJ, Mussá T, Reljic R. Tran AC, et al. Among authors: vergara ej. Front Med (Lausanne). 2023 Oct 9;10:1286785. doi: 10.3389/fmed.2023.1286785. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37877025 Free PMC article.

4

Mucosal and systemic immune responses after a single intranasal dose of nanoparticle and spore-based subunit vaccines in mice with pre-existing lung mycobacterial immunity.

Vergara EJ, Tran AC, Kim MY, Mussá T, Paul MJ, Harrison T, Reljic R. Vergara EJ, et al. Front Immunol. 2023 Dec 7;14:1306449. doi: 10.3389/fimmu.2023.1306449. eCollection 2023. Front Immunol. 2023. PMID: 38130713 Free PMC article.

5

Marked enhancement of the immunogenicity of plant-expressed IgG-Fc fusion proteins by inclusion of cholera toxin non-toxic B subunit within the single polypeptide.

Kim MY, Vergara E, Tran A, Paul MJ, Kwon TH, Ma JKC, Jang YS, Reljic R. Kim MY, et al. Plant Biotechnol J. 2024 May;22(5):1402-1416. doi: 10.1111/pbi.14275. Epub 2024 Jan 1. Plant Biotechnol J. 2024. PMID: 38163285 Free PMC article.

6

Implications of O-glycan modifications in the hinge region of a plant-produced SARS-CoV-2-IgA antibody on functionality.

Uetz P, Göritzer K, Vergara E, Melnik S, Grünwald-Gruber C, Figl R, Deghmane AE, Groppelli E, Reljic R, Ma JK, Stöger E, Strasser R. Uetz P, et al. Front Bioeng Biotechnol. 2024 Mar 6;12:1329018. doi: 10.3389/fbioe.2024.1329018. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38511130 Free PMC article.

7

A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity.

Vergara EJ, Tran AC, Paul MJ, Harrison T, Cooper A, Reljic R. Vergara EJ, et al. NPJ Vaccines. 2024 Jul 2;9(1):123. doi: 10.1038/s41541-024-00906-z. NPJ Vaccines. 2024. PMID: 38956057 Free PMC article.

8

Glehnia littoralis Root Extract Induces G0/G1 Phase Cell Cycle Arrest in the MCF-7 Human Breast Cancer Cell Line.

de la Cruz JF, Vergara EJ, Cho Y, Hong HO, Oyungerel B, Hwang SG. de la Cruz JF, et al. Among authors: vergara ej. Asian Pac J Cancer Prev. 2015;16(18):8113-7. doi: 10.7314/apjcp.2015.16.18.8113. Asian Pac J Cancer Prev. 2015. PMID: 26745047 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters